MCID: GRS003
MIFTS: 50

Griscelli Syndrome malady

Categories: Genetic diseases, Rare diseases, Eye diseases, Skin diseases, Immune diseases, Neuronal diseases, Blood diseases

Aliases & Classifications for Griscelli Syndrome

About this section

Aliases & Descriptions for Griscelli Syndrome:

Name: Griscelli Syndrome 45 23
Griscelli Disease 45 51
Partial Albinism-Immunodeficiency Syndrome 51
Hypopigmentation Immunodeficiency Disease 23
Hypopigmentation-Immunodeficiency Disease 65
 
Partial Albinism with Immunodeficiency 23
Chédiak-Higashi-Like Syndrome 51
Griscelli-Pruniéras Syndrome 51
Gs 23

Characteristics:

Orphanet epidemiological data:

51
griscelli disease:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood

Classifications:



External Ids:

Orphanet51 381
ICD10 via Orphanet28 E70.3
UMLS65 C0398794

Summaries for Griscelli Syndrome

About this section
Genetics Home Reference:23 Griscelli syndrome is an inherited condition characterized by unusually light (hypopigmented) skin and light silvery-gray hair starting in infancy. Researchers have identified three types of this disorder, which are distinguished by their genetic cause and pattern of signs and symptoms.

MalaCards based summary: Griscelli Syndrome, also known as griscelli disease, is related to griscelli syndrome, type 3 and chediak-higashi syndrome, and has symptoms including hypopigmented skin patches, premature graying of hair and hypopigmentation of hair. An important gene associated with Griscelli Syndrome is RAB27A (RAB27A, Member RAS Oncogene Family), and among its related pathways are wtCFTR and deltaF508 traffic / Late endosome and Lysosome (norm and CF) and Deregulation of Rab and Rab Effector Genes in Bladder Cancer. Affiliated tissues include skin, bone and bone marrow, and related mouse phenotype pigmentation.

Wikipedia:68 Griscelli syndrome is a rare autosomal recessive disorder characterized by albinism (hypopigmentation)... more...

Related Diseases for Griscelli Syndrome

About this section

Diseases in the Griscelli Syndrome family:

Griscelli Syndrome, Type 3 Griscelli Syndrome, Type 1
Griscelli Syndrome, Type 2

Diseases related to Griscelli Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 95)
idRelated DiseaseScoreTop Affiliating Genes
1griscelli syndrome, type 333.7MLPH, MYO5A
2chediak-higashi syndrome29.3RAB27A, UNC13D
3griscelli syndrome, type 112.4
4griscelli syndrome, type 212.4
5gitelman syndrome11.0
6chronic infantile neurological cutaneous articular syndrome11.0
7megaloblastic anemia-1, finnish type10.9
8gerstmann syndrome10.9
9congenital brain dysgenesis due to glutamine synthetase deficiency10.9
10cinca syndrome10.9
11pseudohypoparathyroidism10.7
12adenoma10.3
13thyroiditis10.2
14hemophagocytic lymphohistiocytosis10.1
15albinism10.1
16neuroblastoma10.1
17glioma10.1
18albright's hereditary osteodystrophy10.1
19hematopoietic stem cell transplantation10.0
20pseudohypoparathyroidism ic10.0
21gnas hyperfunction10.0
22macrophagic myofasciitis10.0RAB27A, UNC13D
23hepatitis10.0RAB27A, UNC13D
24cholera10.0
25pituitary adenoma10.0
26pituitary tumors10.0
27alzheimer disease10.0
28acrocephalopolydactylous dysplasia9.9
29neuronitis9.9
30peptic ulcer disease9.9RAB27A, UNC13D
31multiple endocrine neoplasia9.9
32mccune-albright syndrome, somatic, mosaic9.9
33pseudohypoparathyroidism, type ib9.9
34gilbert syndrome9.9
35total anomalous pulmonary venous return9.9MLPH, MYO5A, RAB27A
36myelodysplastic syndrome9.8
37hydrocephalus9.8
38lymphomatoid granulomatosis9.8
39obstructive hydrocephalus9.8
40status epilepticus9.8
41melanoma9.8
42dermatitis9.8
43atopic dermatitis9.8
44myositis9.8
45neurologic diseases9.8
46albinism immunodeficiency9.8
47silvery hair syndrome9.8
48leukemia9.8
49lymphoma9.8
50fibrous dysplasia9.8

Graphical network of the top 20 diseases related to Griscelli Syndrome:



Diseases related to griscelli syndrome

Symptoms for Griscelli Syndrome

About this section

Symptoms:

 51 (show all 34)
  • irregular/patchy skin hypopigmentation
  • premature greying of hair
  • albinism (hair)
  • autosomal recessive inheritance
  • lymphadenopathy/polyadenopathies
  • areflexia/hyporeflexia
  • immunodeficiency/increased susceptibility to infections/recurrent infections
  • agammaglobulinemia/hypogammaglobulinemia/b-cell deficiency
  • leukopenia/hypoleukocytosis
  • polynuclear cells/neutrophils anomalies/neutropenia
  • thrombocytopenia/thrombopenia
  • hyperlipidemia/hypercholesterolemia/hypertriglyceridemia
  • iris albinism/ocular albinism
  • nystagmus
  • eyebrows anomalies
  • anomalies of eyelids, eyelashes and lacrimal system
  • ascitis
  • hepatitis/icterus/cholestasis
  • hepatomegaly/liver enlargement (excluding storage disease)
  • splenomegaly
  • edema of the legs/lower limbs
  • encephalocele/exencephaly
  • cortical atrophy without hydrocephaly/cerebral hemiatrophy/subcortical atrophy
  • hydrocephaly
  • cranial nerves palsy
  • ataxia/incoordination/trouble of the equilibrium
  • movement disorder
  • hypotonia
  • hypertonia/spasticity/rigidity/stiffness
  • seizures/epilepsy/absences/spasms/status epilepticus
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • bone marrow failure/pancytopenia
  • short stature/dwarfism/nanism
  • fever/chilling

HPO human phenotypes related to Griscelli Syndrome:

(show all 30)
id Description Frequency HPO Source Accession
1 hypopigmented skin patches hallmark (90%) HP:0001053
2 premature graying of hair hallmark (90%) HP:0002216
3 hypopigmentation of hair hallmark (90%) HP:0005599
4 reduced tendon reflexes typical (50%) HP:0001315
5 thrombocytopenia typical (50%) HP:0001873
6 abnormality of neutrophils typical (50%) HP:0001874
7 leukopenia typical (50%) HP:0001882
8 lymphadenopathy typical (50%) HP:0002716
9 abnormality of lipid metabolism typical (50%) HP:0003119
10 decreased antibody level in blood typical (50%) HP:0004313
11 hydrocephalus occasional (7.5%) HP:0000238
12 abnormality of the eyebrow occasional (7.5%) HP:0000534
13 nystagmus occasional (7.5%) HP:0000639
14 ocular albinism occasional (7.5%) HP:0001107
15 seizures occasional (7.5%) HP:0001250
16 muscular hypotonia occasional (7.5%) HP:0001252
17 hypertonia occasional (7.5%) HP:0001276
18 ascites occasional (7.5%) HP:0001541
19 splenomegaly occasional (7.5%) HP:0001744
20 encephalocele occasional (7.5%) HP:0002084
21 cerebral cortical atrophy occasional (7.5%) HP:0002120
22 hepatomegaly occasional (7.5%) HP:0002240
23 incoordination occasional (7.5%) HP:0002311
24 short stature occasional (7.5%) HP:0004322
25 abnormality of temperature regulation occasional (7.5%) HP:0004370
26 bone marrow hypocellularity occasional (7.5%) HP:0005528
27 cranial nerve paralysis occasional (7.5%) HP:0006824
28 edema of the lower limbs occasional (7.5%) HP:0010741
29 abnormality of movement occasional (7.5%) HP:0100022
30 cognitive impairment occasional (7.5%) HP:0100543

Drugs & Therapeutics for Griscelli Syndrome

About this section

Drugs for Griscelli Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Busulfanapproved, investigationalPhase 2, Phase 350655-98-12478
Synonyms:
1, 4-Dimethanesulfonoxybutane
1, 4-Dimethylsulfonoxybutane
1, {4-Bis[methanesulfonoxy]butane}
1,4-BUTANEDIOL DIMETHANESULFONATE
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulfonyloxy)butane
1,4-Bis[methanesulfonoxy]butane
1,4-Butanedi yl dimethanesulfonate
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethylsulfonate
1,4-Butanediol, dimethanesulfonate
1,4-Butanediol, dimethanesulphonate
1,4-Butanediyl dimethanesulfonate
1,4-Di(methylsulfonoxy)butane
1,4-Dimesyloxybutane
1,4-Dimethane sulfonyl oxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulfonoxylbutane
1,4-Dimethanesulfonyloxybutane
1,4-Dimethanesulphonyloxybutane
1,4-Dimethylsulfonoxybutane
1,4-Dimethylsulfonyloxybutane
2041 C. B
2041 C. B.
2041 C.B
2041 C.B.
4-((Methylsulfonyl)oxy)butyl methanesulfonate
4-methylsulfonyloxybutyl methanesulfonate
55-98-1
AC-198
AC1L1DRQ
AC1Q4GRQ
AI3-25012
AKOS003614975
AN 33501
Ambap55-98-1
B1022
B2635_FLUKA
B2635_SIGMA
BRN 1791786
BSPBio_001920
BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE)
Bisulfex
Busilvex
Busulfan
Busulfan (JP15/USP/INN)
Busulfan GlaxoSmithKline Brand
Busulfan Orphan Brand
Busulfan Wellcome
Busulfan Wellcome Brand
Busulfan [INN:JAN]
Busulfano
Busulfano [INN-Spanish]
Busulfanum
Busulfanum [INN-Latin]
Busulfex
Busulphan
Busulphane
Butanedioldimethanesulfonate
Buzulfan
C.B. 2041
C6H14O6S2
CB 2041
CCRIS 418
CHEBI:28901
CHEMBL820
CID2478
CPD000058613
Citosulfan
D002066
D00248
DB01008
DivK1c_000847
EINECS 200-250-2
FT-0083567
G.T. 41
GT 2041
GT 41
Glaxo Wellcome Brand of Busulfan
GlaxoSmithKline Brand of Busulfan
Glyzophrol
HMS1920I07
HMS2091O09
HMS502K09
 
HSDB 7605
I09-1371
IDI1_000847
InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
KBio1_000847
KBio2_000512
KBio2_003080
KBio2_005648
KBio3_001420
KBioGR_000698
KBioSS_000512
LS-1358
Leucosulfan
MLS001076666
MYLERAN (TN)
Mablin
Methanesulfonic
Methanesulfonic acid, tetram ethylene ester
Methanesulfonic acid, tetramethylene ester
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
MolPort-001-783-406
Myeleukon
Myeloleukon
Myelosan
Myelosanum
Mylecytan
Myleran
Myleran Tablets
Myleran tablets
Myleran, Busulfex, Busulfan
Mylerlan
NCGC00090905-01
NCGC00090905-02
NCGC00090905-03
NCGC00090905-04
NCGC00090905-05
NCGC00090905-06
NCGC00090905-07
NCI-C01592
NCI60_041640
NCIMech_000192
NINDS_000847
NSC 750
NSC-750
NSC-750sulphabutin
NSC750
Orphan Brand of Busulfan
Prestwick_989
S1692_Selleck
SAM002554887
SMR000058613
SPBio_000253
SPECTRUM1500152
ST50825921
Spectrum2_000067
Spectrum3_000320
Spectrum4_000259
Spectrum5_000928
Spectrum_000092
Sulfabutin
Sulfabutin (VAN)
Sulphabutin
Tetramethylene Dimethane Sulfonate
Tetramethylene bis(methanesulfonate)
Tetramethylene bis[methanesulfonate]
Tetramethylene dimethane sulfonate
Tetramethylene {bis[methanesulfonate]}
Tetramethylenester Kyseliny Methansulfonove
Tetramethylenester kyseliny methansulfonove
Tetramethylenester kyseliny methansulfonove [Czech]
UNII-G1LN9045DK
WLN: WS1&O4OSW1
Wellcome Brand of Busulfan
Wellcome, Busulfan
X 149
acid, tetramethylene ester
alkylating agent: crosslinks guanine residues
busulfan
butane-1,4-diyl dimethanesulfonate
n-Butane-1,3-di(methylsulfonate)
2
Cyclophosphamideapproved, investigationalPhase 2, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
3
FludarabineapprovedPhase 2105921679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-Fluoro-ara AMP
2-Fluoroadenine arabinoside 5'-monophosphate
21679-14-1
2F-Ara-AMP
9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate)
9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
 
Fludara, Fludarabine
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine Phosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
Oforta
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
4
MelphalanapprovedPhase 2685148-82-34053, 460612
Synonyms:
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
(2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid
148-82-3
3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3025 C.B.
3025 c.b
3223-07-2
4-(Bis(2-chloroethyl)amino)-L-phenylalanine
4-14-00-01689 (Beilstein Handbook Reference)
4-[Bis(2-chloroethyl)amino]-L-phenylalanine
4-[Bis-(2-chloroethyl)amino]-L-phenylalanine
AC1LA2OE
ALKERAN (TN)
AY3360000
Alanine Nitrogen Mustard
Alkeran
AmbotzHAA1563
At-290
BIDD:GT0044
BRD-K87827419-001-02-8
BRN 2816456
BSPBio_002407
C13H18Cl2N2O2
CB 3025
CB-3025
CCRIS 374
CHEBI:165415
CHEBI:28876
CHEMBL852
CID460612
D00369
DivK1c_000653
EINECS 205-726-3
HMS2090B09
HMS2091B16
HMS502A15
HSDB 3234
IDI1_000653
KBio1_000653
KBio2_000877
KBio2_003445
KBio2_006013
KBio3_001627
KBioGR_001284
KBioSS_000877
L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine
L-PAM
L-Phenylalanine mustard
L-Sarcolysin
L-Sarcolysine
L-Sarkolysin
LS-15868
LS-865
Levofalan
 
Levofolan
Levopholan
M2011_SIGMA
MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN))
MLS001333666
MLS002153368
Melfalan
Melfalano
Melfalano [INN-Spanish]
Melphalan (JP15/USP/INN)
Melphalan Hydrochloride
Melphalan [USAN:INN:BAN:JAN]
Melphalan hydrochloride
Melphalanum
Melphalanum [INN-Latin]
Mephalan
MolPort-003-665-535
NCGC00090757-01
NCGC00090757-02
NCGC00090757-03
NCI-C04853
NINDS_000653
NIOSH/AY3360000
NSC 241286
NSC 8806
NSC-8806
NSC241286
NSC8806
P-Di-(2-chloroethyl)amino-L-phenylalanine
P-L-Sarcolysin
P-N-Bis(2-chloroethyl)amino-L-phenylalanine
Phenylalanine mustard
Phenylalanine nitrogen mustard
Prestwick_1006
RCRA waste no. U150
Rcra waste number U150
SK-15673
SMP2_000174
SMR000058720
SPBio_000287
SPECTRUM1500382
Sarcolysine
Sarkolysin
Spectrum2_000074
Spectrum3_000684
Spectrum4_000882
Spectrum5_001601
Spectrum_000397
TL8001065
TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN)
TRANSGENIC MODEL EVALUATION (MELPHALAN)
UNII-Q41OR9510P
melphalan
p-Bis(beta-chloroethyl)aminophenylalanine
p-Di-(2-chloroethyl)amino-L-phenylalanine
p-L-Sarcolysin
p-L-sarcolysine
p-N,N-bis(2-chloroethyl)amino-L-phenylalanine
p-N-Bis(2-chloroethyl)amino-L-phenylalanine
p-N-Di(chloroethyl)aminophenylalanine
p-N-di(chloroethyl)aminophenylala nine
phenylalanine nitrogen mu stard
5
alemtuzumabapproved, investigationalPhase 2302216503-57-0
Synonyms:
Campath
 
Lemtrada
Mabcampath
alemtuzumab
6Fludarabine phosphatePhase 2105930751
7Antilymphocyte SerumPhase 2388
8
Vidarabineapproved23824356-66-932326, 21704
Synonyms:
(+)-Cyclaradine
.beta.-Adenosine
.beta.-D-Adenosine
1odi
2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2946-52-3
2fqy
2gl0
30143-02-3
3080-29-3
3228-71-5
4005-33-8
46946-45-6
46969-16-8
524-69-6
5536-17-4
58-61-7
9-Arabinosyladenine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl-adenine
9-β-D-arabinofuranosyl-9H-purin-6-amine
9-β-D-arabinofuranosyladenine
A 9251
A0152
A4036_SIGMA
A4676_SIGMA
A5762_SIGMA
A9251_SIGMA
AC1L18OL
AC1L1U8O
AC1L2IWM
AC1L2SCM
AC1O4WIN
AC1O8PY7
AC1Q1ID3
AC1Q4Y1Z
AC1Q52XU
ADENOSINE, U.S.P.
ADN
AI3-52413
AI3-52821
AR-1H6029
ARA-A NSC 247519
Ade-Rib
Adenine Arabinoside
Adenine arabinoside
Adenine nucleoside
Adenine riboside
Adenine xyloside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine arabinose
Adenosine-8-14C
Adensoine
Ambap5536-17-4
Ara A
Ara-A
Ara-ATP
Araadenosine
Arabinoside Adenine
Arabinoside adenine
Arabinosyl Adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
BB_NC-0565
BPBio1_000898
BRN 0624881
BSPBio_000816
BSPBio_001796
BSPBio_002000
Bio1_000437
Bio1_000926
Bio1_001415
Boniton
C00212
CAS-5536-17-4
CCRIS 2557
CCRIS 3383
CHEBI:136932
CHEBI:16335
CHEBI:45327
CHEMBL1090
CHEMBL20247
CHEMBL477
CI 673
CI-673
CID102198
CID191
CID21704
CID60961
CID6420052
CID6713976
CPD000471872
Caswell No. 010B
D000241
D00045
D06298
DB00640
DivK1c_000191
EINECS 200-389-9
EINECS 217-911-6
EINECS 226-893-9
EU-0100123
FT-0082881
HMS1570I18
HMS1920A13
HMS1921K05
HMS2090F06
HMS2091G13
HMS2092C16
HMS500J13
HSDB 6514
 
I01-1121
IDI1_000191
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001296
KBio3_001500
KBioGR_001224
KBioSS_002424
L000094
LS-15059
LS-15085
Lopac0_000123
MEDR-640
MLS000069638
MLS000699527
MLS001066352
MLS001333133
MLS001333134
MLS002153227
MLS002153992
MolPort-001-785-903
MolPort-001-838-229
MolPort-003-666-308
Myocol
NCGC00016656-01
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
NCGC00178869-01
NCGC00179417-01
NCI60_003823
NCI60_037192
NCIOpen2_003303
NCIOpen2_005376
NINDS_000191
NSC 247519
NSC 404241
NSC 627048
NSC 7359
NSC 7652
NSC-404241
NSC247519
NSC404241
NSC627048
NSC70422
NSC7359
NSC7652
NSC80832
NSC87676
NSC91041
Nucleocardyl
PDSP1_001036
PDSP2_001020
Pallacor
Polyadenosine
Polyriboadenosine
Prestwick0_000768
Prestwick1_000768
Prestwick2_000768
Prestwick3_000768
Prestwick_983
RAB
S1647_Selleck
S1784_Selleck
SAM002564191
SMP1_000312
SMR000058216
SMR000225041
SMR000471872
SMR001233326
SPBio_001194
SPBio_001491
SPBio_002755
SPECTRUM1500107
SPECTRUM1500609
SR 96225
SR-96225
STK361815
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum2_001336
Spectrum3_000288
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spectrum_001894
Spongoadenosine
TL8003749
UNII-3XQD2MEW34
UNII-K72T3FS567
USAF CB-10
V0098
VIRDARABINE
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine
Vidarabine (JAN)
Vidarabine anhydrous
Vidarabinum
Vira ATM
Vira-A
Vira-A, Vidarabine
XA
Xylosyl A
Xylosyladenine
ZINC00970363
ZINC02169830
adenine-D-ribose
adenosine
alpha-Ara A
beta-Adenosine
beta-Ara A
beta-D-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.64-comp4
nchembio706-5
9Immunologic Factors18483
10Immunosuppressive Agents10422
11Protective Agents5651
12Antiviral Agents8071
13
Mesna2433375-50-6598
Synonyms:
2-Mercaptoethanesulfonate
2-Mercaptoethanesulfonic acid
 
CoM
Coenzyme M
HS-CoM
14Antimetabolites9454
15Alkylating Agents3582
16Anti-Infective Agents17220
17Antimetabolites, Antineoplastic5770
18Antineoplastic Agents, Alkylating3406
19Antirheumatic Agents8496

Interventional clinical trials:

idNameStatusNCT IDPhase
1T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersActive, not recruitingNCT00176826Phase 2, Phase 3
2Stem Cell Transplant for Immunologic or Histiocytic DisordersActive, not recruitingNCT00176865Phase 2
3Study of Megakaryocytes From Patients With Abnormal Platelet VesiclesCompletedNCT00086476
4Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesRecruitingNCT01652092

Search NIH Clinical Center for Griscelli Syndrome

Genetic Tests for Griscelli Syndrome

About this section

Anatomical Context for Griscelli Syndrome

About this section

MalaCards organs/tissues related to Griscelli Syndrome:

33
Skin, Bone, Bone marrow, Neutrophil, T cells, Kidney, B cells

Animal Models for Griscelli Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Griscelli Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011868.8MLPH, MYO5A, RAB27A, RAB27B

Publications for Griscelli Syndrome

About this section

Articles related to Griscelli Syndrome:

(show top 50)    (show all 87)
idTitleAuthorsYear
1
Griscelli syndrome type 2: A rare and fatal syndrome in a South Indian boy. (26960655)
2016
2
Seizure as the presenting manifestation in griscelli syndrome type 2. (25801174)
2015
3
Griscelli Syndrome Type 3: Two New Cases and Review of the Literature. (26337734)
2015
4
Cerebellar involvement of Griscelli syndrome type 2. (25315806)
2014
5
Griscelli syndrome type 3-like phenotype with MYO-5A exon-F deletion. (25283056)
2014
6
Griscelli syndrome. (25500851)
2014
7
A rare pigmentary disorder in two non-identical siblings: Griscelli Syndrome -type 3. (25046460)
2014
8
Teaching neuroImages: Griscelli syndrome and CNS lymphohistiocytosis. (24711539)
2014
9
An Indian boy with griscelli syndrome type 2: case report and review of literature. (25071262)
2014
10
Griscelli syndrome: a case report. (25657774)
2014
11
Molecular analysis and clinical findings of Griscelli syndrome patients. (22983416)
2012
12
Griscelli syndrome: hemophagocytic lymphohistiocytosis with silvery hair. (23436972)
2012
13
Griscelli syndrome associated with hemophagocytic lymphohistiocytosis. (23135662)
2012
14
Silvery hair syndrome in two cousins: Chediak-Higashi syndrome vs Griscelli syndrome, with rare associations. (22223973)
2011
15
Pulmonary lymphomatoid granulomatosis in Griscelli syndrome type 2. (22111599)
2011
16
Myositis in Griscelli syndrome type 2 treated with hematopoietic cell transplantation. (20034795)
2010
17
Premature birth, respiratory distress, intracerebral hemorrhage, and silvery-gray hair: differential diagnosis of the 3 types of Griscelli syndrome. (20661159)
2010
18
Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2. (20591709)
2010
19
Griscelli syndrome type 2: long-term follow-up after unrelated donor bone marrow transplantation. (19270433)
2009
20
Griscelli syndrome: a model system to study vesicular trafficking. (19243575)
2009
21
A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). (18991284)
2008
22
A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome. (18397837)
2008
23
Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot. (18350256)
2008
24
Griscelli syndrome type 2: a rare and lethal disorder. (18403584)
2008
25
Griscelli syndrome and electroencephalography pattern. (18641887)
2008
26
Griscelli syndrome: a case report. (17786788)
2007
27
Griscelli syndrome type 2; a pediatric case with immunodeficiency. (17893437)
2007
28
Griscelli syndrome. (17483661)
2007
29
Development of in situ melanoma after allogeneic bone marrow transplantation in Griscelli syndrome type II. (17910659)
2007
30
Neurological presentation of Griscelli syndrome: obstructive hydrocephalus without haematological abnormalities or organomegaly. (17085000)
2007
31
Bilateral basal ganglia involvement in a patient with Griscelli syndrome. (16952471)
2006
32
Rab27b is up-regulated in human Griscelli syndrome type II melanocytes and linked to the actin cytoskeleton via exon F-Myosin Va transcripts. (15357836)
2004
33
Griscelli syndrome: a rare immunodeficiency disorder with partial albinism. (15187349)
2004
34
Myelodysplastic features in Griscelli syndrome. (15111776)
2004
35
Griscelli syndrome. (15053385)
2004
36
Comment on Elejalde syndrome and relationship with Griscelli syndrome. (12522801)
2003
37
Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients. (12446441)
2003
38
Partial albinism, immunodeficiency, hypergammaglobulinemia and Dandy-Walker cyst--a Griscelli syndrome variant. (14581742)
2003
39
Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. (12122117)
2002
40
Griscelli syndrome: report of a case and review of the literature. (11380929)
2001
41
Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome. (11014477)
2000
42
Accelerated phase in partial albinism with immunodeficiency (Griscelli syndrome): genetics and stem cell transplantation in a 2-month-old girl. (10653334)
2000
43
Arg-Cys substitution at codon 1246 of the human myosin Va gene is not associated with Griscelli syndrome. (10733681)
2000
44
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. (10835631)
2000
45
Myelodysplastic syndrome associated with Griscelli syndrome. (9716020)
1998
46
Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature. (9486701)
1998
47
Griscelli syndrome: report of three cases. (8597818)
1995
48
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement. (7977308)
1994
49
Partial albinism with immunodeficiency (Griscelli syndrome). (7996360)
1994
50

Variations for Griscelli Syndrome

About this section

Expression for genes affiliated with Griscelli Syndrome

About this section
Search GEO for disease gene expression data for Griscelli Syndrome.

Pathways for genes affiliated with Griscelli Syndrome

About this section

Pathways related to Griscelli Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7RAB27A, UNC13D
28.8MLPH, RAB27A, RAB27B, UNC13D

GO Terms for genes affiliated with Griscelli Syndrome

About this section

Cellular components related to Griscelli Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1melanosomeGO:00424709.7MYO5A, RAB27B
2late endosomeGO:00057709.4RAB27A, UNC13D
3recycling endosomeGO:00550379.2MYO5A, RAB11FIP1

Biological processes related to Griscelli Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1melanocyte differentiationGO:003031810.0MYO5A, RAB27A
2pigmentationGO:00434739.9MYO5A, RAB27A
3vesicle-mediated transportGO:00161929.7MYO5A, RAB27A
4multivesicular body sorting pathwayGO:00719859.3RAB27A, RAB27B
5positive regulation of exocytosisGO:00459219.2RAB27A, RAB27B, UNC13D

Sources for Griscelli Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet